Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1 - Wikidata - awgldk - TriplyDB

Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1

Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1

http://www.wikidata.org/entity/Q35135046

about

Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism Protection from cerebral ischemia by inhibition of TGFβ-activated kinase Protection of the ischemic myocardium during the reperfusion: between hope and reality.Myocardial postconditioning: next step to cardioprotection.Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction.Gadd45γ regulates cardiomyocyte death and post-myocardial infarction left ventricular remodelling.Insights into innate immune signalling in controlling cardiac remodelling.

P2860

Q35218899-2036B902-345A-4C26-A8BF-55637B3607BD Q36162153-99572775-EC32-4045-BD40-AC9755E76265 Q36190291-8A08FAE5-4F8D-4190-967C-08E932AA2FC3 Q37942779-811ED0A3-0D0E-458E-A269-18BF9C8C6E39 Q40435871-4A6163DC-F4C9-41CE-BC5D-3E9190BA532A Q41360692-9E0F0FF7-26F4-47DD-A722-1B10EC7614C3 Q52448624-200BD7C8-0425-4D34-8933-B384FB05A204

P2860

Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1

http://www.wikidata.org/entity/Q35135046

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@ast

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@en

type

label

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@ast

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@en

prefLabel

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@ast

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@en

P1433

Q35135046-A8AC568A-3EF9-48EE-832E-F5F2DE6AD36F

P1476

Q35135046-F4814706-BECD-4543-85B2-CC9E20CF4E9D

P2093

Q35135046-30D981B7-8DB2-4C25-B8AE-0CFD22780CB2

Q35135046-9DA6D1DE-2A89-41F6-8453-35030D9AB794

Q35135046-DD7A02B0-0719-4101-8B3F-C25861D44D6D

P2860

Q35135046-071EF61A-95AC-4F5C-AD16-4FC84FF927AB

Q35135046-0C62623F-E06D-4A9F-9E63-07A5F6D2C207

Q35135046-1AA2DED8-E2F4-443C-9D2C-37DC12491623

Q35135046-1ECF802F-4679-4B91-AE20-18DB6493EB2F

Q35135046-25004577-2D1C-4C29-B79D-22D39B0F02EF

Q35135046-2CB176D4-9A52-4BCA-A359-502BD38EBC8F

Q35135046-35CE9811-6497-4F00-AE5A-16EB7C0014C3

Q35135046-3831ED88-D0C6-4483-AF36-5BC7475B510C

Q35135046-3A1579FB-08FF-49D8-B40E-2C9C18A66871

Q35135046-407D4F6B-E272-45B2-B447-73DDDA88030D

P304

Q35135046-CC4F4F15-06B2-4733-B112-F578693AC89F

P31

Q35135046-EF697B6B-9F6D-47C5-91EE-8464100C2FBF

P356

Q35135046-D4EEA479-F972-46F3-BB2D-A1008A889EB7

P433

Q35135046-EBE4E734-6169-4FAD-8FD6-5F1060F3040C

P478

Q35135046-7CFE9ED0-E991-43C2-A20F-05E7F7DA648E

P50

Q35135046-94DE72E4-E375-4AAB-B8BA-E0EE98923281

Q35135046-E01CA4E5-6FDB-4790-86E0-ACE66347A4BB

P577

Q35135046-E48BBB8F-5E2D-43C5-B000-9283292FDD29

P5875

Q35135046-E3F37A57-9939-4B67-AC65-137729135001

P698

Q35135046-3DC91FAD-0ADD-4443-BD65-336DAA1935FD

P932

Q35135046-96D3015E-BBDE-4710-85BB-982F76B2424E

P356

P1433

Cardiovascular Research

P1476

Pharmacological postconditioni ...... mediated through RIP2 and TAK1

@en

P2093

Koichi S Kobayashi

http://www.w3.org/2001/XMLSchema#string

Richard A Flavell

http://www.w3.org/2001/XMLSchema#string

Sebastien Jacquet

http://www.w3.org/2001/XMLSchema#string

P2860

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia

Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats

Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection

Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts

The novel adipocytokine visfatin exerts direct cardioprotective effects

Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury

Sepsis and the heart.

Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart

P304

277-284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVP055

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Marber

P577

2009-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24004815

http://www.w3.org/2001/XMLSchema#string

P698

19213760

http://www.w3.org/2001/XMLSchema#string

P932

3146014

http://www.w3.org/2001/XMLSchema#string